These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22561144)

  • 1. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Gershman MD; Staples JE; Bentsi-Enchill AD; Breugelmans JG; Brito GS; Camacho LA; Cottin P; Domingo C; Durbin A; Gascon J; Guenaneche F; Hayes EB; Jelenik Z; Khromava A; Martins Rde M; Wilson MM; Massy N; Nasidi A; Niedrig M; Sherwat A; Tsai T; Vilella A; Wilson ME; Kohl KS;
    Vaccine; 2012 Jul; 30(33):5038-58. PubMed ID: 22561144
    [No Abstract]   [Full Text] [Related]  

  • 2. Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Cutland CL; Lackritz EM; Mallett-Moore T; Bardají A; Chandrasekaran R; Lahariya C; Nisar MI; Tapia MD; Pathirana J; Kochhar S; Muñoz FM;
    Vaccine; 2017 Dec; 35(48 Pt A):6492-6500. PubMed ID: 29150054
    [No Abstract]   [Full Text] [Related]  

  • 3. Antenatal bleeding: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Prabhu M; Eckert LO; Belfort M; Babarinsa I; Ananth CV; Silver RM; Stringer E; Meller L; King J; Hayman R; Kochhar S; Riley L;
    Vaccine; 2017 Dec; 35(48 Pt A):6529-6537. PubMed ID: 29150058
    [No Abstract]   [Full Text] [Related]  

  • 4. Dysfunctional labor: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Boatin AA; Eckert LO; Boulvain M; Grotegut C; Fisher BM; King J; Berg M; Adanu RMK; Reddy U; Waugh JJS; Gupta M; Kochhar S; Kenyon S;
    Vaccine; 2017 Dec; 35(48 Pt A):6538-6545. PubMed ID: 29150059
    [No Abstract]   [Full Text] [Related]  

  • 5. Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Easter SR; Eckert LO; Boghossian N; Spencer R; Oteng-Ntim E; Ioannou C; Patwardhan M; Harrison MS; Khalil A; Gravett M; Goldenberg R; McKelvey A; Gupta M; Pool V; Robson SC; Joshi J; Kochhar S; McElrath T;
    Vaccine; 2017 Dec; 35(48 Pt A):6546-6554. PubMed ID: 29150060
    [No Abstract]   [Full Text] [Related]  

  • 6. Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Sweet LR; Keech C; Klein NP; Marshall HS; Tagbo BN; Quine D; Kaur P; Tikhonov I; Nisar MI; Kochhar S; Muñoz FM;
    Vaccine; 2017 Dec; 35(48 Pt A):6506-6517. PubMed ID: 29150056
    [No Abstract]   [Full Text] [Related]  

  • 7. Spontaneous abortion and ectopic pregnancy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Rouse CE; Eckert LO; Babarinsa I; Fay E; Gupta M; Harrison MS; Kawai AT; Kharbanda EO; Kucuku M; Meller L; Mallett Moore T; Subelj M; Kochhar S; Tavares-Da-Silva F; ;
    Vaccine; 2017 Dec; 35(48 Pt A):6563-6574. PubMed ID: 29150062
    [No Abstract]   [Full Text] [Related]  

  • 8. Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Kachikis A; Eckert LO; Walker C; Oteng-Ntim E; Guggilla R; Gupta M; Patwardhan M; Mataya R; Mallett Moore T; Alguacil-Ramos AM; Keech C; Gravett M; Murphy H; Kochhar S; Chescheir N;
    Vaccine; 2017 Dec; 35(48 Pt A):6555-6562. PubMed ID: 29150061
    [No Abstract]   [Full Text] [Related]  

  • 9. Can reporting of adverse drug reactions create safer systems while improving health data?
    Hohl C; Lexchin JR; Balka E
    CMAJ; 2015 Aug; 187(11):789-790. PubMed ID: 25941261
    [No Abstract]   [Full Text] [Related]  

  • 10. Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.
    Sell E; Munoz FM; Soe A; Wiznitzer M; Heath PT; Clarke ED; Spiegel H; Sawlwin D; Šubelj M; Tikhonov I; Mohammad K; Kochhar S;
    Vaccine; 2017 Dec; 35(48 Pt A):6501-6505. PubMed ID: 29150055
    [No Abstract]   [Full Text] [Related]  

  • 11. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data.
    Sejvar JJ; Kohl KS; Bilynsky R; Blumberg D; Cvetkovich T; Galama J; Gidudu J; Katikaneni L; Khuri-Bulos N; Oleske J; Tapiainen T; Wiznitzer M;
    Vaccine; 2007 Aug; 25(31):5771-92. PubMed ID: 17570566
    [No Abstract]   [Full Text] [Related]  

  • 12. Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.
    DeSilva M; Munoz FM; Sell E; Marshall H; Tse Kawai A; Kachikis A; Heath P; Klein NP; Oleske JM; Jehan F; Spiegel H; Nesin M; Tagbo BN; Shrestha A; Cutland CL; Eckert LO; Kochhar S; Bardají A;
    Vaccine; 2017 Dec; 35(48 Pt A):6472-6482. PubMed ID: 29150052
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure to thrive: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.
    Ross E; Munoz FM; Edem B; Nan C; Jehan F; Quinn J; Mallett Moore T; Sesay S; Spiegel H; Fortuna L; Kochhar S; Buttery J;
    Vaccine; 2017 Dec; 35(48 Pt A):6483-6491. PubMed ID: 29150053
    [No Abstract]   [Full Text] [Related]  

  • 14. Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.
    Schlaudecker EP; Munoz FM; Bardají A; Boghossian NS; Khalil A; Mousa H; Nesin M; Nisar MI; Pool V; Spiegel HML; Tapia MD; Kochhar S; Black S;
    Vaccine; 2017 Dec; 35(48 Pt A):6518-6528. PubMed ID: 29150057
    [No Abstract]   [Full Text] [Related]  

  • 15. Statistical methods for the analysis of adverse event data.
    Kieser M
    Pharm Stat; 2016 Jul; 15(4):290-1. PubMed ID: 27324410
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of reporting bias in the analysis of spontaneous reporting data.
    Ghosh P; Dewanji A
    Pharm Stat; 2015; 14(1):20-5. PubMed ID: 25376637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards Drug Safety Surveillance and Pharmacovigilance: Current Progress in Detecting Medication and Adverse Drug Events from Electronic Health Records.
    Liu F; Jagannatha A; Yu H
    Drug Saf; 2019 Jan; 42(1):95-97. PubMed ID: 30649734
    [No Abstract]   [Full Text] [Related]  

  • 18. Report of Adverse Events in Colombia: A Successful Case.
    Moreno-Mattar O; Ramírez R; Alvarado A; Sierra F; Guzmán J
    Curr Drug Saf; 2019; 14(1):53-56. PubMed ID: 30411692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute aseptic arthritis: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.
    Woerner A; Pourmalek F; Panozzo C; Pileggi G; Hudson M; Caric A; Abraham S; Varricchio F; Velasco C; Oleske J; Bauwens J; Bonhoeffer J;
    Vaccine; 2019 Jan; 37(2):384-391. PubMed ID: 30342899
    [No Abstract]   [Full Text] [Related]  

  • 20. Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005-2017.
    Yoon D; Kim JH; Lee H; Shin JY
    Yonsei Med J; 2020 Jul; 61(7):623-630. PubMed ID: 32608206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.